DM
ORIC icon

Deerfield Management’s Oric Pharmaceuticals ORIC Stock Holding History

Deerfield Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-78,435
Closed -$804K – 329
2024
Q3 		$804K Buy
+78,435
New +$776K 0.01% 189
2020
Q3 		– Sell
-300,000
Closed -$10.1M – 111
2020
Q2 		$10.1M Buy
+300,000
New +$9.58M 0.29% 76

Other funds holding ORIC

P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management's ORIC Position: Q4 2024 in Review

Deerfield Management sold out of Oric Pharmaceuticals (ORIC) in Q4 2024, closing a stake of 78,435 shares — an estimated $804K sold.

Deerfield Management first reported a position in ORIC in Q2 2020 and held it in 2 quarters. The position peaked at $10.1M in Q2 2020. 129 funds tracked by Wall St. Rank hold ORIC as of Q4 2024.

  • Deerfield Management reported no remaining Oric Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Deerfield Management sold 78,435 Oric Pharmaceuticals shares in Q4 2024, an estimated $804K.
  • Deerfield Management first reported a position in Oric Pharmaceuticals in Q2 2020 and held it in 2 quarters.
  • Deerfield Management's Oric Pharmaceuticals position peaked at $10.1M in Q2 2020.
  • 129 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q4 2024.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.